Cardiorentis Competitors and Similar CompaniesClear all

Travere Therapeutics's competitors and similar companies include Ventria Bioscience and Immunicum.

	Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.	Ventria Bioscience Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.	Immunicum Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
Founding Date	Founding Date 2011	Founding Date 1993	Founding Date 2002
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations San Diego, US HQ Dublin, IE	Locations Junction City, US HQ Aurora, US	Locations Stockholm, SE HQ Leiden, NL
Employees	Employees 46293% increase	Employees 244% decrease	Employees 28
Valuation ($)	Valuation ($) 1.4 b	Valuation ($) N/A	Valuation ($) 49.3 m
Financial
Revenue (est.)	Revenue (est.) $490.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $10.3m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $480.4m (FY, 2025)	Gross profit N/A	Gross profit kr7.8m (FY, 2025)
Net income	Net income ($25.5m) (FY, 2025)	Net income N/A	Net income (kr113.3m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 25m	Total funding raised $ 7.7m	Total funding raised N/A